美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ultra納斯達克生物科

120.91

-1.2531-1.03%

盤後：120.88-0.0260-0.02%19:30 EDT

成交量：1.67萬

成交額：200.79萬

市值：1.03億

市盈率：- -

高：123.15

開：123.15

低：118.50

收：122.16

52周最高：126.40

52周最低：54.56

股本：85.00萬

流通股本：85.00萬

量比：0.72

換手率：1.96%

股息：0.32

股息率：0.26%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

歐盟委員會擴大吉利德Trodelvy®在轉移性三陰性乳腺癌一線治療中的應用範圍，覆蓋所有PD-L1狀態

吉利德科學：歐盟批准Trodelvy聯合Keytruda用於一線PD-L1陽性轉移性三陰性乳腺癌

美國聯邦貿易委員會（FTC）：安進專利申請收購交易受到反壟斷審查。

Piper Sandler上調安進目標價至457美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/BIB"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BIB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","market":"US","secType":"STK","nameCN":"Ultra納斯達克生物科","latestPrice":120.906,"timestamp":1787601600000,"preClose":122.1591,"halted":0,"volume":16661,"hourTrading":{"tag":"盘后","latestPrice":120.88,"preClose":120.906,"latestTime":"19:30 EDT","volume":21,"amount":2541.108,"timestamp":1787614251807,"change":-0.026,"changeRate":-0.000215,"amplitude":0},"delay":0,"changeRate":-0.010257934120339698,"floatShares":850000,"shares":850000,"eps":0,"marketStatus":"已收盤","change":-1.2531,"latestTime":"08-24 16:00:00 EDT","open":123.15,"high":123.15,"low":118.5,"amount":2007898.5822899998,"amplitude":0.038065,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":122.1591,"sharesOutstanding":1040000,"nav":122.0953,"aum":103781005,"dividendRate":0.002627,"bidAskSpread":0.002683,"preHourTrading":{"tag":"盘前","latestPrice":121.38,"preClose":122.1591,"latestTime":"09:29 EDT","volume":16,"amount":1982.31296,"timestamp":1787578185014,"change":-0.7791,"changeRate":-0.006378,"amplitude":0.021957},"postHourTrading":{"tag":"盘后","latestPrice":120.88,"preClose":120.906,"latestTime":"19:30 EDT","volume":21,"amount":2541.108,"timestamp":1787614251807,"change":-0.026,"changeRate":-0.000215,"amplitude":0},"volumeRatio":0.721006,"impliedVol":0.515,"impliedVolPercentile":0.8645},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","floatShares":850000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.721006,"shares":850000,"dividePrice":0.3176,"high":123.15,"amplitude":0.038065,"preClose":122.1591,"low":118.5,"week52Low":54.5634,"pbRate":"--","week52High":126.399,"institutionHeld":0,"latestPrice":120.906,"eps":0,"divideRate":0.002627,"volume":16661,"delay":0,"ttmEps":0,"open":123.15,"prevYearClose":79.7794,"prevWeekClose":122.1591,"prevMonthClose":96.6087,"prevQuarterClose":100.74,"fiveDayClose":109.8842,"twentyDayClose":98.6003,"sixtyDayClose":84.8397},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIB\",params:#limit:5,,,undefined,":[{"date":"2026-03-25","symbol":"BIB","amount":0.00714,"announcedDate":"2026-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-25","defaultRemindTime":1774445400000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-25","currency":"USD","dateTimestamp":1774411200000,"payDate":"2026-03-31"},{"date":"2025-12-24","symbol":"BIB","amount":0.134637,"announcedDate":"2025-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-24","defaultRemindTime":1766586600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-24","currency":"USD","dateTimestamp":1766552400000,"payDate":"2025-12-31"},{"date":"2025-09-24","symbol":"BIB","amount":0.180541,"announcedDate":"2025-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-24","defaultRemindTime":1758720600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-24","currency":"USD","dateTimestamp":1758686400000,"payDate":"2025-09-30"},{"date":"2025-06-25","symbol":"BIB","amount":0.170576,"announcedDate":"2025-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-07-01"},{"date":"2025-03-26","symbol":"BIB","amount":0.130939,"announcedDate":"2025-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-26","defaultRemindTime":1742995800000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-26","currency":"USD","dateTimestamp":1742961600000,"payDate":"2025-04-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIB\",market:\"US\",,,undefined,":[{"executeDate":"2022-12-22","recordDate":"2022-12-23","paymentDate":"2022-12-30","value":0.019852,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-28","value":0.038393,"currency":"USD"},{"executeDate":"2024-03-20","recordDate":"2024-03-21","paymentDate":"2024-03-27","value":0.040324,"currency":"USD"},{"executeDate":"2024-06-26","recordDate":"2024-06-26","paymentDate":"2024-07-03","value":0.26476,"currency":"USD"},{"executeDate":"2024-09-25","recordDate":"2024-09-25","paymentDate":"2024-10-02","value":0.15285,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIB\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1186632498","title":"歐盟委員會擴大吉利德Trodelvy®在轉移性三陰性乳腺癌一線治療中的應用範圍，覆蓋所有PD-L1狀態","url":"https://stock-news.laohu8.com/highlight/detail?id=1186632498","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186632498?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:32","pubTimestamp":1787567559,"startTime":"0","endTime":"0","summary":"欧盟委员会近日作出重要决定，将吉利德科学（Gilead Sciences）旗下重磅药物Trodelvy®的适用范围进一步拓宽。此次调整聚焦于转移性三阴性乳腺癌的一线治疗领域，且不再受限于患者的PD-L1表达状态。这一举措意味着，无论生物标志物检测结果如何，符合条件的患者均有望从该疗法中获益。此举不仅为临床医生提供了更为灵活的用药选择，也标志着Trodelvy®在肿瘤治疗版图中的地位得到显著提升。吉利德科学方面对此表示积极回应，认为该批准将助力满足更多患者未被满足的医疗需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","LU0965508806.USD","LU2089984988.USD","LU2468319806.SGD","LU0320765992.SGD","LU0114720955.EUR","LU1023059063.AUD","TBXU","LU1057294990.SGD","IE00B19Z3581.USD","IBB","SG9999015986.USD","SG9999015945.SGD","LU2112291526.USD","BK4566","LU1674673428.USD","BK4532","LU1037948541.HKD","LU0109394709.USD","LU0234570918.USD","LU1934455194.USD","LU1061106388.HKD","LU1066051498.USD","IE00B3T34201.USD","LU1934455863.HKD","IE00BKVL7J92.USD","BK4568","GILD","LU0122379950.USD","BK4583","LU0965509010.AUD","LU0058720904.USD","LU2357627491.SGD","BK4585","IBBQ","LU2324357040.USD","LU0965509283.SGD","BK4588","LU1430594728.SGD","LU2087621335.USD","SG9999015978.USD","LU1585245621.USD","BK4578","BMED","BBH","LU0823416689.USD","LU0889565916.HKD","MEDI","LU1778281490.HKD","IE0002270589.USD","LU0882574055.USD","LU1839511570.USD","LU0861579265.USD","LU0289739699.SGD","IE00BZ1G4Q59.USD","LU1037948897.HKD","LU1066053197.SGD","LU1571399168.USD","LU1934455277.USD","SG9999015952.SGD","TMED","LU0965509101.SGD","BK4139","LU1674673691.USD","IE00B19Z3B42.SGD","LU0859254822.USD","IE00BSNM7G36.USD","IE00B7SZLL34.SGD","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193380081","title":"吉利德科學：歐盟批准Trodelvy聯合Keytruda用於一線PD-L1陽性轉移性三陰性乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1193380081","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193380081?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:32","pubTimestamp":1787567533,"startTime":"0","endTime":"0","summary":"吉利德科学公司宣布，欧盟已正式授予其抗体药物偶联物Trodelvy与默沙东的Keytruda联合用药方案的上市许可。这一批准针对的是既往未经治疗的PD-L1阳性转移性三阴性乳腺癌患者群体。此项授权标志着该联合疗法在欧盟地区的临床可及性迈出关键一步，为这类侵袭性强、治疗选择有限的乳腺癌亚型患者提供了新的一线治疗选项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015945.SGD","LU0823416689.USD","BMED","LU1023059063.AUD","IE0002270589.USD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU0234570918.USD","LU1430594728.SGD","LU1778281490.HKD","LU1674673691.USD","LU2324357040.USD","LU1066053197.SGD","LU0058720904.USD","BK4585","LU1934455863.HKD","TBXU","LU1934455194.USD","IBBQ","LU0109394709.USD","LU0965509101.SGD","TMED","BK4532","LU0289739699.SGD","LU1585245621.USD","LU0882574055.USD","BK4588","LU0965509283.SGD","LU2112291526.USD","SG9999015978.USD","GILD","IE00B7SZLL34.SGD","LU0320765992.SGD","BK4550","LU0114720955.EUR","SG9999015952.SGD","LU1934455277.USD","IE00BSNM7G36.USD","BBH","IE00B3T34201.USD","BK4578","BK4566","LU2357627491.SGD","LU0122379950.USD","IE00BZ1G4Q59.USD","LU1037948897.HKD","LU1839511570.USD","BIB","LU0965509010.AUD","BK4568","LU1066051498.USD","LU0889565916.HKD","LU1061106388.HKD","LU2468319806.SGD","LU0861579265.USD","LU2087621335.USD","BK4139","LU0965508806.USD","LU1057294990.SGD","LU1571399168.USD","LU1674673428.USD","BK4583","MEDI","IE00B19Z3581.USD","LU2089984988.USD","LU0859254822.USD","SG9999015986.USD","LU1037948541.HKD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661291370","title":"美國聯邦貿易委員會（FTC）：安進專利申請收購交易受到反壟斷審查。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661291370","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661291370?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 23:49","pubTimestamp":1787327356,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HCA","AMGN","KEMQ","JHMT","PNQI","TRUC","CWC","ARB","GOOX","MSFY","BUYO","IBB","GXPT","MUSQ","LRGG","TBXU","RSPT","WEBX","JHCS","ORCZ","IXP","PBS","IEME","TGRW","NBCC","DRUP","PBE","MSFX","PJP","BWEB","GXPC","DISC","WEBL","BBH","GGTL","QQMG","BCTK","MNA","BIB","FCOM","XLCI","FTC","MRGR","EVNT","TDAQ","ONEQ","IBBQ","NBDS","EMQQ","IHF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250489","title":"Piper Sandler上調安進目標價至457美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250489","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250489?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 15:20","pubTimestamp":1787296801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IBBQ","LU1571399168.USD","UDN","IE0002141913.USD","BK4533","IE00BJT1NW94.SGD","SG9999001440.SGD","BK4534","LU2112291526.USD","BK4588","LU0122379950.USD","LU2089984988.USD","PBE","UUP","BBH","PJP","LU0109394709.USD","IE00BJJMRZ35.SGD","LU1983299246.USD","LU1057294990.SGD","LU0889565916.HKD","BK4599","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU2242652126.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","LU0868494617.USD","BK4139","BIB","TBXU","LU1061106388.HKD","IE0009355771.USD","BK4581","LU0289739699.SGD","BK4566","IBB","BK4585","LU2242646821.SGD","AMGN","LU0320765992.SGD","IE00B2B36J28.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":25,"pageCount":1,"totalSize":100,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BIB\",params:#limit:6,delay:false,,,undefined,":[]}}